Evidence map›Paper›PMID 24764034›Full record

Trial reportEuropean journal of nuclear medicine and molecular imaging2014

Characterizing IgG4-related disease with ¹⁸F-FDG PET/CT: a prospective cohort study.

Jingjing Zhang, Hua Chen, Yanru Ma, Yu Xiao, Na Niu, Wei Lin, Xinwei Wang, Zhiyong Liang, Fengchun Zhang, Fang Li and 2 more

Open access · hybridAbstract readClinical Trial
In one paragraph

Trial report in European journal of nuclear medicine and molecular imaging, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 102 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
102citing papers in PubMed, 3 pooled it
18.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

102 citing papers in PubMed, 3 syntheses or guidelines pooled it, 234 citations in OpenAlex.

  1. Guideline
  2. Immunoglobulin G4-related hypertrophic pachymeningitis: A case-oriented review.Neurology(R) neuroimmunology & neuroinflammation · 2019
    Pooled it
  3. Pooled it
  4. IgG4-related orbital disease - An update.Indian journal of ophthalmology · 2026
    Review
  5. Article
  6. Article
  7. Complete Treatment Response of Isolated Lacrimal IgG4-Related Disease onMolecular imaging and radionuclide therapy · 2026
    Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. [Application ofBeijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences · 2024
    Article
  18. Volume-Based Quantitative Measurement of [Molecular imaging and biology · 2024
    Article
  19. Review
  20. Appropriate timing to perform an interimAnnals of hematology · 2024
    Article

42 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Jingjing ZhangDepartment of Nuclear Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, No. 1 Shuaifuyuan, Wangfujing Street, Dongcheng District, Beijing, 100730, China.
Hua Chen
Yanru Ma
Yu Xiao
Na Niu
Wei Lin
Xinwei Wang
Zhiyong Liang
Fengchun Zhang
Fang Li
Wen Zhang
Zhaohui Zhu
Chinese Academy of Medical Sciences & Peking Union Medical College · CNPeking Union Medical College Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeIgG4-related disease (IgG4-RD) is an increasingly recognized clinicopathological disorder with immune-mediated inflammatory lesions mimicking malignancies. A cohort study was prospectively designed to investigate the value of (18)F-fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) in characterizing IgG4-RD.

methodsThirty-five patients diagnosed with IgG4-RD according to the consensus criteria were enrolled with informed consent. All patients underwent baseline (18)F-FDG PET/CT evaluation. Among them, 29 patients underwent a second (18)F-FDG PET/CT scan after 2 to 4 weeks of steroid-based therapy.

resultsAll 35 patients were found with (18)F-FDG-avid hypermetabolic lesion(s); 97.1% (34/35) of these patients showed multi-organ involvement. Among the 35 patients, 71.4% (25/35) patients were found with more organ involvement on (18)F-FDG PET/CT than conventional evaluations including physical examination, ultrasonography, and computed tomography (CT). (18)F-FDG PET/CT demonstrated specific image characteristics and pattern of IgG4-RD, including diffusely elevated (18)F-FDG uptake in the pancreas and salivary glands, patchy lesions in the retroperitoneal region and vascular wall, and multi-organ involvement that cannot be interpreted as metastasis. Comprehensive understanding of all involvement aided the biopsy-site selection in seven patients and the recanalization of ureteral obstruction in five patients. After 2 to 4 weeks of steroid-based therapy at 40 mg to 50 mg prednisone per day, 72.4% (21/29) of the patients showed complete remission, whereas the others exhibited > 81.8% decrease in (18)F-FDG uptake.

conclusionF-FDG PET/CT is a useful tool for assessing organ involvement, monitoring therapeutic response, and guiding interventional treatment of IgG4-RD. The image pattern is suggested to be updated into the consensus diagnostic criteria for IgG4-RD.

Indexed as

Fluorodeoxyglucose F18Multimodal ImagingPositron-Emission TomographyRadiopharmaceuticalsTomography, X-Ray ComputedAdultAgedAutoimmune DiseasesCohort StudiesFemaleHumansImmunoglobulin GMaleMiddle AgedProspective StudiesFluorodeoxyglucose F18Immunoglobulin GRadiopharmaceuticals

Identifiers

PMID24764034
PMCPMC4089015
OpenAlexW2032963354

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.